The SGC is a public-private partnership that supports the discovery of new medicines through open access research.
Welcome to SGC
Acta Crystallogr D Biol Crystallogr
Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
J Med Chem
Proc Natl Acad Sci U S A
There are currently no open vacancies with the SGC. Please check back periodically for opportunities which may arise in both Oxford and Toronto.